25021-239 : Gemcitabine 38 mg/ml Intravenous Injection, Solution


NDC: 25021-239
Labeler: Sagent Pharmaceuticals
Product Type: Human Prescription Drug
Drug Name:  Gemcitabine
Dosage Form: Intravenous Injection, Solution
Application #: ANDA209077
Rev. Date: 


NDC Package Codes:

  • 25021-239-05: 1 VIAL IN 1 CARTON (25021‑239‑05) > 5.26 ML IN 1 VIAL
  • 25021-239-26: 1 VIAL IN 1 CARTON (25021‑239‑26) > 26.3 ML IN 1 VIAL
  • 25021-239-52: 1 VIAL IN 1 CARTON (25021‑239‑52) > 52.6 ML IN 1 VIAL

Active Ingredients:

  • Gemcitabine Hydrochloride

Dosage Strength:

  • 38 mg/mL

Pharmaceutical Classes:

  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Nucleoside Metabolic Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 25021-208 Gemcitabine 200 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 25021-209 Gemcitabine 1 g/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 25021-234 Gemcitabine 200 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 25021-235 Gemcitabine 1 g/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Sagent Pharmaceuticals
  • 0143-9394 Gemcitabine 200 mg Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0143-9395 Gemcitabine 1 g/1 Intravenous Injection, Powder, Lyophilized, for Solution by Hikma Pharmaceuticals USA Inc.
  • 0409-0181 Gemcitabine 38 mg/ml Intravenous Injection, Solution by Hospira, Inc.
  • 0409-0182 Gemcitabine 38 mg/ml Intravenous Injection, Solution by Hospira, Inc.
  • 0409-0183 Gemcitabine 38 mg/ml Intravenous Injection, Solution by Hospira, Inc.
  • 0409-0185 Gemcitabine 38 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0409-0186 Gemcitabine 38 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 0409-0187 Gemcitabine 38 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira, Inc.
  • 16714-909 Gemcitabine 200 mg Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rx LLC
  • 16714-930 Gemcitabine 1 g/1 Intravenous Injection, Powder, Lyophilized, for Solution by Northstar Rx LLC
  • 16729-391 Gemcitabine 100 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
  • 16729-419 Gemcitabine 100 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
  • 16729-423 Gemcitabine 100 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
  • 16729-426 Gemcitabine 100 mg/ml Intravenous Injection, Solution by Accord Healthcare Inc.
  • 45963-623 Gemcitabine 38 mg/ml Intravenous Injection by Actavis Pharma, Inc.
  • 45963-624 Gemcitabine 38 mg/ml Intravenous Injection by Actavis Pharma, Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 25021-239 QR Code

< Prev: 25021-237Next: 25021-241 >

Related Discussions:

GEMCITABINE/GEMZAK
CHEMOTHERAPY ## What is the dosage of gemcitabin + Mannitol +Sodium Acetate Combination... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.